The American Society of Clinical Oncology (ASCO) shared on X:
“Diwakar Davar and Jason Luke of UPMC Hillman Cancer Center discuss exciting advances in high-risk melanoma from the NADINA trial and other emerging approaches in immunotherapy from ASCO24 on the ASCO Daily News Podcast.”
Source: ASCO/X